Literature DB >> 9502133

The use of pericardium in acquired heart disease: a review article.

T E David1.   

Abstract

Pericardium is an excellent material for reconstruction of the heart during the surgical management of certain acquired heart defects. This review details our experience with pericardium as a patch material for various parts of the left ventricle. MITRAL ANNULUS: Extensive calcification of the mitral annulus, abscess, multiple previous mitral valve replacements and rupture of the posterior wall of the left ventricle are challenging surgical problems that can be satisfactorily managed by reconstructing the mitral annulus with either fresh autologous or glutaraldehyde-fixed bovine pericardium. The mitral valve prosthesis is secured to the newly reconstructed mitral annulus. This procedure has proven to be durable and has provided very good long-term results. LEFT VENTRICULAR OUTFLOW TRACT: We have used bovine pericardium to enlarge the aortic annulus in patients with small aortic annulus undergoing aortic valve replacement with bioprosthetic valves. Patch enlargement of the aortic annulus probably increases the operative mortality of aortic valve replacement but it may favorably effect the clinical outcome and late survival. Another problem in the aortic root that frequently requires reconstruction with pericardium is aortic root abscess. We believe that radical resection of the abscess is the single most important component to eradicate infection in these patients. Pericardium is an excellent material to reconstruct all parts of the left ventricular outflow tract and the results have been excellent. RECONSTRUCTION OF THE LEFT VENTRICULAR WALL: We have also used pericardium to repair the left ventricle in patients with postinfarction ventricular septal defect. We have used a technique of infarct exclusion by suturing a properly tailored bovine pericardium to the endocardium of the left ventricle all around the infarct, excluding the left ventricular cavity from the infarcted wall. This technique has improved the outcome of surgery for this mechanical complication of myocardial infarction, particularly in patients with posterior interventricular septal rupture.

Entities:  

Mesh:

Year:  1998        PMID: 9502133

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  6 in total

1.  Is autologous or heterologous pericardium better for valvuloplasty? A comparative study of calcification propensity.

Authors:  Wen-Jian Jiang; Yong-Chao Cui; Jin-Hua Li; Xiu-Hui Zhang; Huan-Huan Ding; Yong-Qiang Lai; Hong-Jia Zhang
Journal:  Tex Heart Inst J       Date:  2015-06-01

2.  Bladder repair following iatrogenic cystotomy in irradiated small capacity bladders.

Authors:  J Y Chee; P Durai; F M Wu; H Y Tiong
Journal:  Singapore Med J       Date:  2015-03       Impact factor: 1.858

3.  Fresh Autologous Pericardium to Reconstruct the Pulmonary Valve at the Annulus When Tetralogy of Fallot Requires a Transannular Patch at Midterm.

Authors:  Shantanu Pande; Jugal K Sharma; C R Siddartha; Anubhav Bansal; Surendra K Agarwal; Prabhat Tewari; Aditya Kapoor
Journal:  Tex Heart Inst J       Date:  2016-06-01

4.  Rapid anticalcification treatment for glutaraldehyde-fixed autologous tissue in cardiovascular surgery.

Authors:  Shotaro Kaneko; Susumu Isoda; Toru Aoyama; Motohiko Goda; Shota Yasuda; Taisuke Shibuya; Mai Matsumura; Hideaki Mitsui; Koji Okudela; Shinichi Suzuki; Daisuke Machida; Munetaka Masuda
Journal:  J Cardiothorac Surg       Date:  2022-05-31       Impact factor: 1.522

5.  Application of the CardioCel bovine pericardial patch - a preliminary report.

Authors:  Michał Sobieraj; Edyta Cudak; Wojciech Mrówczyński; Tomasz K Nałęcz; Przemysław Westerski; Michał Wojtalik
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-09-30

6.  Mitral paravalvular abscess with left ventriculo-atrial fistula in a patient on dialysis.

Authors:  Tadashi Kitamura; James Edwards; Suchi Khurana; Robert G Stuklis
Journal:  J Cardiothorac Surg       Date:  2009-07-16       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.